Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness
| Status: | Not yet recruiting |
|---|---|
| Conditions: | Depression, Depression, Schizophrenia, Smoking Cessation, Smoking Cessation, Major Depression Disorder (MDD), Psychiatric, Psychiatric, Bipolar Disorder |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 7/28/2016 |
| Start Date: | December 2016 |
| End Date: | June 2020 |
| Contact: | Melissa C Maravic, PhD, MPH |
| Email: | melissa.maravic@mgh.harvard.edu |
| Phone: | 617-643-1771 |
The overall aim of this study is to test the effect of academic detailing (i.e.
provider-level educational intervention focused on evidence-based smoking cessation
treatment for those with psychiatric illness), alone or in combination with practical
support from a community health worker, on the provision and utilization of standard of care
smoking cessation treatment to those with serious mental illness (SMI). Further, this study
will determine if these interventions improve smoking cessation rates for adults with SMI
who smoke.
provider-level educational intervention focused on evidence-based smoking cessation
treatment for those with psychiatric illness), alone or in combination with practical
support from a community health worker, on the provision and utilization of standard of care
smoking cessation treatment to those with serious mental illness (SMI). Further, this study
will determine if these interventions improve smoking cessation rates for adults with SMI
who smoke.
In this study, the investigators aim to test whether a provider-level educational
intervention in the form of targeted, practical, action-oriented education to primary care
physicians and nurses on safety and effectiveness of and how to use evidence-based smoking
cessation treatment for those with psychiatric illness, termed academic detailing (AD),
alone or in combination with practical support offered to the primary care physician /
primary care team and the smoker with SMI in the form of a community health worker (CHW)
will improve recommendation and utilization of standard of care smoking cessation treatments
to and by those with SMI and, if so, whether the intervention improves smoking cessation
rates for adults with SMI who smoke.
To do so, the investigators will randomize primary care clinics that serve approximately
1300 adult smokers with SMI who receive psychiatric rehabilitation services, Community Based
Flexible Support (CBFS) or Assertive Community Treatment (ACT)), from the two largest
providers of these services in the Boston area to either receive AD for their prescribers or
not in a cluster randomized design. Half of the smokers with SMI in the study who receive
primary care at the clinics assigned to the AD intervention to providers will be randomly
assigned to be offered CHW support in addition to their ongoing psychiatric rehabilitation
(CBFS or ACT) services.
intervention in the form of targeted, practical, action-oriented education to primary care
physicians and nurses on safety and effectiveness of and how to use evidence-based smoking
cessation treatment for those with psychiatric illness, termed academic detailing (AD),
alone or in combination with practical support offered to the primary care physician /
primary care team and the smoker with SMI in the form of a community health worker (CHW)
will improve recommendation and utilization of standard of care smoking cessation treatments
to and by those with SMI and, if so, whether the intervention improves smoking cessation
rates for adults with SMI who smoke.
To do so, the investigators will randomize primary care clinics that serve approximately
1300 adult smokers with SMI who receive psychiatric rehabilitation services, Community Based
Flexible Support (CBFS) or Assertive Community Treatment (ACT)), from the two largest
providers of these services in the Boston area to either receive AD for their prescribers or
not in a cluster randomized design. Half of the smokers with SMI in the study who receive
primary care at the clinics assigned to the AD intervention to providers will be randomly
assigned to be offered CHW support in addition to their ongoing psychiatric rehabilitation
(CBFS or ACT) services.
Inclusion:
- adult (18+ years)
- current smoker
- current diagnosis of SMI (e.g. schizophrenia, bipolar disorder, major depressive
disorder, etc...)
- currently receiving psychiatric rehabilitation services through CBFS and ACT programs
at Bay Cove Human Services and Vinfen Corporation
Exclusion:
- intellectual disability (IQ<70)
We found this trial at
1
site
Boston, Massachusetts 02114
Principal Investigator: A Eden Evins, MD, MPH
Phone: 617-643-1771
Click here to add this to my saved trials
